Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2021-12-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer
NCT03304132
The Oral Microbiome in OSCC
NCT04925700
Impact of the Oral Microbiota on Relapse in HNSCC Patients
NCT06807034
The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw
NCT03418454
Exfoliated Cytology in Detection of Oral Premalignant and Malignant Lesions
NCT04955197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with no oral malignant disease
No interventions assigned to this group
Patients with oral premalignant disease
No interventions assigned to this group
Patients with oral malignant disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients are (partially) dentate (≥20 teeth)
* Patients who have given written informed consent to participate in this study
Exclusion Criteria
* Patients with a history of chemotherapy, immunotherapy or immunomodulating drugs
* Patients with a previous malginancy in head and neck region
* Edentulous patients (with or without implants)
* Patients with removable (partial) dentures
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Academisch Ziekenhuis Maastricht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eliza Hagens
Drs. L.A.A. Vaassen & Dr. E.R.C. Hagens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deptartment of Oral and Maxillofacial Surgery, Maastricht UMC+
Maastricht, , Netherlands
Department of Cranio- & Maxillofacial surgery, Radboud UMC
Nijmegen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METC 2019-1251
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.